Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancer

NCT01394211 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Estrogen Receptor-positive Breast Cancer
Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
Male Breast Cancer
Recurrent Breast Cancer
Stage II Breast Cancer
Stage IIIA Breast Cancer
Stage IIIB Breast Cancer

Interventions

DRUG: anastrozole
DRUG: pazopanib hydrochloride
PROCEDURE: therapeutic conventional surgery

Sponsor

University of Arizona

Collaborators

[object Object]
[object Object]